3V Medical Research Group
Pre-clinical3V Medical Research Group is developing Luxsol™, a suspension intended for use as a targeted therapy to prevent and treat Covid-19 and Influenza, and Ostrolux™, a cream intended to manage pain associated with osteoarthritis and the severe discomfort of radiation dermatitis .
Founded
2018
Focus
Drug Delivery
About
3V Medical Research Group is developing Luxsol™, a suspension intended for use as a targeted therapy to prevent and treat Covid-19 and Influenza, and Ostrolux™, a cream intended to manage pain associated with osteoarthritis and the severe discomfort of radiation dermatitis .
Company Info
TypePrivate
Founded2018
LocationMiami, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile